Revenue
2022
2023
2024
2025
GENELUX Corp (GNLX)
Price—Loading quote
Net income
2022
2023
2024
2025
Free cash flow
2022
2023
2024
2025
Total cash / debt
CashTotal debt
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Revenue | $8,000 | $8,000 | $170,000 | $11.1M |
| Research & development | $19.9M | $19.0M | $12.8M | $9.1M |
| Operating expenses | $33.2M | $31.7M | $24.3M | $14.1M |
| Operating income | −$33.2M | −$31.7M | −$24.2M | −$3.0M |
| Net income | −$32.1M | −$29.9M | −$28.3M | −$5.2M |
| Basic EPSper diluted share | -$0.86 | -$0.95 | -$1.16 | -$0.57 |
| Diluted EPSper diluted share | -$0.86 | -$0.95 | -$1.16 | -$0.57 |
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jun 3, 2026Form 4 | Smalling RalphHead of Regulatory | SellCommon Stock | 192 | $2.93 | $562.56 | 67.6K |
| Jun 1, 2026Form 4 · 10b5-1 | Thomas JohnDirector | SellCommon Stock | 10.0K | $2.98 | $29.8K | 472.8K |
| May 11, 2026Form 4 | Cappello JosephChief Technical Officer | SellCommon Stock | 605 | $2.97 | $1.8K | 154.5K |
| May 11, 2026Form 4 | Yu YongChief Scientific Officer | SellCommon Stock | 605 | $2.97 | $1.8K | 149.7K |
| May 11, 2026Form 4 | Zindrick ThomasPresident and CEO | SellCommon Stock | 2.8K | $2.94 | $8.2K | 532.1K |